Articles
| Open Access |
DOI: Assessment Of Clinical And Psychological Status And Quality Of Life Of Patients In Different Forms Of Irritable Bowel Syndrome
Abdullayev R.B. , Urgench Branch Of The Tashkent Medical Academy, Khorezm, Uzbekistan Makhmudova L.I. , Bukhara State Medical Institute, Bukhara, UzbekistanAbstract
Irritable bowel syndrome (IBS) is a biopsychosocial disorder that consists of a set of functional disorders that cannot be explained by organic changes in the intestines. At present, it is very important to determine the indicators of quality of life (QOL) in patients with various diseases. QOL analysis allows us to determine how well a patient is coping with the disease, and is also important for addressing many of the issues that arise during treatment. The main complaints of patients were fecal incontinence (100%) and pain syndrome (100%). In patients with IBS with predominance of diarrhea and constipation, the leading symptom in the clinical picture of the disease is pain throughout the bowel, which decreases or disappears after defecation, accompanied by flatulence and a feeling of complete bowel emptying. ± 0.25 points (according to the results of the GSRS survey), which corresponds to severe and moderate intensity pain syndrome. At the end of the course of treatment, a statistically significant decrease in the intensity of abdominal pain was observed in patients.
Keywords
Irritable bowel syndrome,, quality of life, psychological status
References
Sheptulin A.A., Vize-Xripunova M.A. New in the etiology and pathogenesis of irritable bowel syndrome. Klinicheskaya medIBSina. 2016-94-2-92-96.
Xanyukov A.A., Fedorova N.S. Possibilities and perspectives in the diagnosis of functional pathology of the intestine. O zdorove rebenka. - Ukraine, 2017-12-2.1-57-61.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712–21.
Pogromov A.P., Mnatsakanyan M.G., Tashchyan O.V. The prevalence of irritable bowel syndrome. Klinicheskaya medIBSina. 2016-94-11-869-874.
Maev I.V., Cheremushkin S.V., Kucheryavyy Yu.A., Cheremushkina N.V. irritable bowel syndrome. Roman Criteria IV. Consilium Medicum. 2016; 18 (8): 79-85.
Maev I.V., Cheremushkin S.V., Kucheryavyy Yu.A. Irritable bowel syndrome. Roman Criteria IV. O role of visceral hyperchuvstvitelnosti i sposobax ee korrektsii. Methodical manual. M., 2016.
Baryshnikova N., Belousova L., Petrenko V., Pavlova E. Assess the quality of life of gastroenterologic patients. Vrach. 2013-62-65.
World Gastroenterology Organization global guidelines irritable bowel syndrome: a global perspective / M.M. Eamonn. et al. - 2015. - 30 r.
Shlyakova A.E., Pantyuxina A.S., Benderskaya E.Yu. Kachestva jizni bolnyx s syndrom razdrajennogo kishechnika v protsesse lecheniya. Health and education in the XXI century. 2017-19-10-143-145.
Blake M.R., Raker J.M., Whelan K. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. 2016 Oct; 44 (7): 693-703. doi: 10.1111 / apt.13746. Epub 2016 Aug 5.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.